Evidence mapPaperPMID 34026753Full record

ArticleFrontiers in cell and developmental biology2021

Pyk2/MCU Pathway as a New Target for Reversing Atherosclerosis.

Yingzhen Zhang, Xiaoli Yang, Zhongzhong Li, Kailin Bu, Tong Li, Zhizhao Ma, Binbin Wang, Lina Ma, Honglin Lu, Kun Zhang and 9 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cell and developmental biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. FAK Family Kinases: A Potential Therapeutic Target for Atherosclerosis.Diabetes, metabolic syndrome and obesity : targets and therapy · 2024
    Review
  5. Modulation of the mitochondrial CaPhysiological reports · 2023
    Article
  6. The mitochondrial CaScientific reports · 2022
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 3 institutions in 1 country.

Yingzhen ZhangDepartment of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
Xiaoli YangDepartment of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
Zhongzhong LiDepartment of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
Kailin BuDepartment of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
Tong LiDepartment of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
Zhizhao MaNeurosurgery Department, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
Binbin WangDepartment of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
Lina MaDepartment of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
Honglin LuDepartment of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
Kun ZhangDepartment of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
Luji LiuDepartment of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
Yanying ZhaoDepartment of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
Yipu ZhuDepartment of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
Jin QinDepartment of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
Junzhao CuiDepartment of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
Lin LiuDepartment of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
Shuxia LiuDepartment of Basic Medicine, Hebei Medical University, Shijiazhuang, China.
Ping FanDepartment of Basic Medicine, Hebei Medical University, Shijiazhuang, China.
Xiaoyun LiuDepartment of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
Hebei Medical University · CNSecond Hospital of Hebei Medical University · CNHebei University of Engineering · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ApoE–/– miceatherosclerosisHUVECsmitochondrionPyk2/MCU

Identifiers

PMID34026753
PMCPMC8134689
OpenAlexW3158412877

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.